Why this matters — Three distinct ORTEX data points have aligned on NMR in a 48-hour window, just days before the Japanese investment bank reports quarterly results on April 24. The convergence of options sentiment, short interest acceleration, and cost-to-borrow dynamics suggests traders are taking defensive positions.
Options traders turn sharply bearish. On April 21, Nomura's put/call ratio surged to 1.98, nearly triple the 20-day average of 0.81. The Z-score of 2.94 standard deviations marks an extreme level of bearish positioning. For most of April, the PCR hovered around 0.73-0.79. The sudden spike indicates traders are loading up on downside protection or directional puts ahead of the earnings release.
Short interest accelerates into event. Shares short jumped 9.4% in one day to 2.20 million on April 22. Over the past week, short interest climbed 18.3%, the fastest weekly surge in recent months. Despite the increase, utilization remains modest at 17.85%, well below the 52-week high of 34.71% hit on March 31. The pace of shorting mirrors the options sentiment shift.
Cost to borrow collapses despite rising short interest. NMR's CTB fell 52% over the past week to 1.31%, down from 2.73% on April 15. The decline follows a March 31 spike to 16.76%. The drop suggests ample supply to borrow despite increased shorting activity, indicating little stress in the lending market. This backdrop makes shorting cheaper and easier ahead of the event.
Nomura saw similar convergence in late March. Short interest spiked to 3.88 million shares on March 31, utilization hit 34.71%, and CTB reached 16.76% — all while the PCR climbed from 0.20 to 0.60. That episode resolved quickly, with short interest falling nearly 50% by April 10 and CTB normalizing. The current setup differs in magnitude but shares the pre-event clustering pattern.
This convergence report is based on ORTEX data and is not financial advice.
See the live data behind this article on ORTEX.
Open NMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
